Health care stocks were steady pre-bell Wednesday as the Health Care Select Sector SPDR Fund (XLV) and the iShares Biotechnology ETF (IBB) were flat recently.
Cross Country Healthcare (CCRN) shares surged past 62% after the company and Aya Healthcare announced an agreement under which Aya will acquire Cross Country Healthcare for $18.61 per share in cash for roughly $615 million in transaction value.
Heron Therapeutics (HRTX) shares rose by over 72% after the company said it won a patent dispute over its Cinvanti injectable emulsion against Fresenius Kabi USA.
Novavax (NVAX) shares were up over 2% after the company said it has agreed to sell its manufacturing facility in Bohumil, Czech Republic, to Novo Nordisk (NVO) for $200 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.